| Role |
Name |
Disclosure |
Details |
| Author | Anthony W Solomon, MBBS, DTM&H, PhD, MRCP, Specialist Registrar in Infectious Diseases, Lister Unit, Northwick Park Hospital, London; Honorary Lecturer, International Centre for Eye Health, Clinical Research Unit, London School of Hygiene and Tropical Medicine, London | Pfizer Inc International Trachoma Initiative Pfizer Inc | Details | | Coauthor | Hugh Ringland Taylor AC, MD, MBBS, BmedSc (Melb), DO (Melb), FRACO, FRACS, FAAO, FACS, FAICD, Harold Mitchell Professor of Indigenous Eye Health, School of Population Health, University of Melbourne | Nothing to disclose | Details | | Medical Editor | Anastasios J Kanellopoulos, MD, Assistant Program Director, Clinical Associate Professor, Department of Ophthalmology, Manhattan Eye, Ear, and Throat Hospital, New York University | Nothing to disclose | Details | | Pharmacy Editor | Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles | Nothing to disclose | Details | | Managing Editor | Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital | Allergan Allergan Alcon Inspire RPS | Details | | CME Editor | Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri | Nothing to disclose | Details | | Chief Editor | Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Anastasios J Kanellopoulos, Medical Editor |
The contributor discloses no conflict of interest. |
|